PRLog (Press Release)
- Nov. 28, 2011 -
The company has been listed as a SPAC (Special Purpose Acquisition Company) for the sole purpose of acquiring a company wishing to go public quickly.
The company is actively looking at all opportunities in the resource sector, preferably in the Health Care or Biotech markets. Companies looking to be listed and trading in order to raise capital for their project should contact the company’s Corporate Advisors, Antevorta Capital Partners Ltd., Mr. Julius Csurgo or Mr. Stephen Wheatley
About GXG UK Markets
GXG Markets UK, London OTC Exchange, is a dedicated UK market operation offering the full range of its market and trading solutions to SMEs within the UK.
GXG Markets operates a Regulated Market that delivers an efficient and transparent trading platform specifically designed to meet the needs of small- and micro-cap companies offering “new ways” in IPO’s and Capital Markets.
ANTEVORTA CAPITAL PARTNERS is a designated corporate advisor on the GXG UK exchange and offers one-stop financial service solutions. We have experienced professionals with the necessary skills, market exposure and know how about overseas exchange venues to assist potential clients in every aspect of the IPO process, at home and abroad.
Cautionary Note Regarding Forward-looking Statements
Certain statements contained in this news release may constitute forward-looking information, within the meaning of UK securities laws. Forward-looking information may relate to this news release and other matters identified in the Company’s public filings, Forward-looking information and anticipated events or results and can be identified by terminology such as “may”, “will”, “could”, “should”, “expect”, “plan”, “anticipate”
, “believe”, “intend”, “estimate”
, “predict”, “potential”
or other similar expressions concerning matters that are not historical facts and include, but are not limited in any manner to, those with respect to capital and operating expenditures, economic conditions, availability of sufficient financing, receipt of approvals, satisfaction of closing conditions and any and all other timing, development, operational, financial, economic, legal, regulatory and/or political factors that may influence future events or conditions. Such forward-looking statements are based on a number of material factors and assumptions, including, but not limited in any manner, those disclosed in any other public filings of the Company, and include the ultimate availability and final receipt of required approvals, sufficient working capital for development and operations, access to adequate services and supplies, availability of markets for products, commodity prices, foreign currency exchange rates, interest rates, access to capital markets and other sources of financing and associated cost of funds, availability of a qualified work force, availability of manufacturing equipment, no material changes to the tax and regulatory regime and the ultimate ability execute its business plan on economically favourable terms. While we consider these assumptions to be reasonable based on information currently available to us, they may prove to be incorrect. Actual results may vary from such forward-looking information for a variety of reasons, including but not limited to risks and uncertainties disclosed in other Company filings and other unforeseen events or circumstances. Other than as required by law, the Company does not intend, or undertake any obligation to update any forward looking information to reflect, among other things, new information or future events.
Neither the GXG Markets UK nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
For more information please go to www.antevortacapital.com
Or contact the company at firstname.lastname@example.org.